Gastrointestinal disorders (Basel, Switzerland)最新文献_第10页

Development of a Motility Frailty Index in Patients with Gastroparesis 胃轻瘫患者运动无力指数的建立

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-04-25 DOI: 10.3390/GIDISORD3020008

J. Winston, Patricia Guzmán Rojas, A. Stocker, P. Mathur, D. Lorenz, M. Daniels, T. Abell

{"title":"Development of a Motility Frailty Index in Patients with Gastroparesis","authors":"J. Winston, Patricia Guzmán Rojas, A. Stocker, P. Mathur, D. Lorenz, M. Daniels, T. Abell","doi":"10.3390/GIDISORD3020008","DOIUrl":"https://doi.org/10.3390/GIDISORD3020008","url":null,"abstract":"Introduction: Patients with symptoms (Sx) of gastrointestinal (GI) motor disorders have limitations in physical strength and mobility. We hypothesized that physical frailty correlated with severity of GI symptoms, and that a motility frailty index (MFI) could be constructed. Patients: We conducted a prospective pilot study on 40 patients, (38 F, 2 M, mean age 39.9 years) with the following diagnoses: 10 with diabetes mellitus and 30 with non-diabetic/idiopathic disorders. Upper and lower GI Sx were quantified using an FDA-compliant, traditional patient-reported outcomes (PRO) system. Methods: Patients underwent a series of physical performance measures involving standing balance (SB), usual walk speed (UW), and chair sit-and-stands (CS). A GI motility frailty index (MFI) was constructed by fitting several models with a combination of physical performance measures and correlating with PRO. Pearson’s correlation compared the constructed index with the GI Sx PRO to construct a GI MFI. Results: The studied patients collectively showed marked limitations in mobility compared with standard performance values with mean (sd) ratios of SB = 0.87 (0.20), UW = 0.45 (0.13), and CS = 0.38 (0.17). Correlations between physical mobility and GI Sx were noted for upper GI Sx (rho = 0.47, p = 0.002) but not for lower GI Sx. Conclusions: In this pilot study of patients with GI motility disorders, we found increased physical limitations on performance-based testing, which had a statistically significant positive correlation with severity of upper GI motor Sx using a standardized PRO system. A motility frailty index has been constructed that may serve as a basis for better quantifying limitations in patient mobility.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":"3 1","pages":"78-83"},"PeriodicalIF":0.0,"publicationDate":"2021-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/GIDISORD3020008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41832798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease 炎症性肠病儿童自我管理技能及相关评估工具综述

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-03-30 DOI: 10.3390/GIDISORD3020007

A. Vernon-Roberts, R. Gearry, A. Day

引用次数: 2

Clinical Impact of Sarcopenia on Gastrointestinal Tumors Sarcopenia对胃肠道肿瘤的临床影响

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-03-23 DOI: 10.3390/GIDISORD3010006

Ana Pereira, J. Pereira, Sandra F. Martins

引用次数: 3

Median Arcuate Ligament Syndrome Clinical Presentation, Pathophysiology, and Management: Description of Four Cases 中弓形韧带综合征的临床表现、病理生理学和治疗——附4例报告

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-02-26 DOI: 10.3390/GIDISORD3010005

Ihsan Al Bayati, M. Gajendran, B. Davis, Jesus Diaz, R. McCallum

引用次数: 6

Acknowledgment to Reviewers of Gastrointestinal Disorders in 2020 感谢2020年胃肠道疾病审稿人

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-01-27 DOI: 10.3390/gidisord3010003

引用次数: 0

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2021-01-14 DOI: 10.3390/GIDISORD3010002

Laura Appleton, A. Day

{"title":"Disease-Related Knowledge in New Zealand Children with Inflammatory Bowel Disease (IBD) and Their Parents","authors":"Laura Appleton, A. Day","doi":"10.3390/GIDISORD3010002","DOIUrl":"https://doi.org/10.3390/GIDISORD3010002","url":null,"abstract":"Insufficient disease-related knowledge can be a barrier to the effective management of the unpredictable and lifelong course of inflammatory bowel disease (IBD). Patients with chronic illnesses have high non-adherence rates, with direct clinical consequences. While no single intervention strategy can improve the adherence of all patients, the success of attempts to improve patient adherence depends upon the realistic assessment of patients’ knowledge and their understanding of the regimen. The aim of this study was to assess the disease-specific knowledge of the parents and patients with IBD in the South Island of New Zealand, and identify areas of poor knowledge. Families of children diagnosed with IBD were asked to complete the IBD Knowledge Inventory Device (IBD-KID). Patients 10 years and older were asked to participate along with their parents. Of 110 families, 91 responded, with completed questionnaires received from 153 parents and 66 patients. Overall, parents scored significantly higher (13.64 ± 3.88) than their children (10.03 ± 4.07; p < 0.001). Areas of poor knowledge included aspects of treatment (both conventional and alternative), along with long-term disease outcomes. This study has shown clear areas of concern in this population’s disease-specific knowledge of their disease. This should be addressed through targeted education for both the patient and the parents to improve not only their knowledge, but also their adherence and disease self-management.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/GIDISORD3010002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69992158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Unfolded Protein Response and Crohn’s Diseases: A Molecular Mechanism of Wound Healing in the Gut 展开蛋白反应与克罗恩病：肠道创伤愈合的分子机制

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2020-12-23 DOI: 10.20944/preprints202012.0578.v1

Chao Li

{"title":"Unfolded Protein Response and Crohn’s Diseases: A Molecular Mechanism of Wound Healing in the Gut","authors":"Chao Li","doi":"10.20944/preprints202012.0578.v1","DOIUrl":"https://doi.org/10.20944/preprints202012.0578.v1","url":null,"abstract":"Endoplasmic reticulum (ER) stress triggers a series of signaling and transcriptional events termed the unfolded protein response (UPR). Severe ER stress is associated with the development of fibrosis in different organs, including lung, liver, kidney, heart, and intestine. ER stress is an essential response of epithelial and immune cells in the pathogenesis of Inflammatory Bowel Disease (IBD), including Crohn’s disease (CD). Intestinal epithelial cells are susceptible to ER stress-mediated damage due to secretion of a large amount of proteins that are involved in mucosal defense. In other cells, ER stress is linked to myofibroblast activation, extracellular matrix production, macrophage polarization, and immune cell differentiation. This review focuses on the role of the UPR in the pathogenesis in IBD from an immunologic perspective. The roles of macrophage and mesenchymal cells in the UPR from in vitro and in vivo animal models are discussed. The links between ER stress and other signaling pathways, such as senescence and autophagy, are introduced. Recent advances in the understanding of the epigenetic regulation of the UPR signaling are also updated here. The future directions of development of the UPR research and therapeutic strategies to manipulate ER stress levels are also reviewed.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45422343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine Her-2在癌症后胃肠道肿瘤中的作用：精准医学工具

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2020-12-22 DOI: 10.3390/gidisord3010001

C. Lengyel, B. Habeeb, S. Khan, K. El Bairi, S. C. Altuna, S. Hussain, S. Mazher, D. Trapani, A. Petrillo

{"title":"Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine","authors":"C. Lengyel, B. Habeeb, S. Khan, K. El Bairi, S. C. Altuna, S. Hussain, S. Mazher, D. Trapani, A. Petrillo","doi":"10.3390/gidisord3010001","DOIUrl":"https://doi.org/10.3390/gidisord3010001","url":null,"abstract":"Gastrointestinal (GI) tumors account for a quarter of all the cancer burden and a third of the global cancer-related mortality. Among them, some cancers retain a dismal prognosis; therefore, newer and innovative therapies are urgently needed in priority disease areas of high-unmet medical need. In this context, HER2 could be a relevant prognostic and predictive biomarker acting as a target for specific drugs. However, if the role of HER2 has been object of investigation for several years in gastric cancer, it is not well established in other GI malignancies. The aim of this narrative review was to portray the current landscape of the potential role of HER2 as a predictive biomarker for GI tumors beyond gastric cancer. In colon cancer, the benefit from anti-HER2 therapies is less clear than in gastric neoplasms for the lack of controlled studies. Pancreatic, biliary tract adenocarcinomas and hepatocarcinoma may derive a less clear clinical benefit by using anti-HER2 agents in HER2 positive tumors. Overall, the results are promising and seem to suggest that the integration of multiple modalities of therapies can optimize the cancer care. However, further prospective trials are needed to validate the use of personalized targeted therapies in this field.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/gidisord3010001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47031862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Ureteral Stent and Percutaneous Nephrostomy in Managing Malignant Ureteric Obstruction of Gastrointestinal Origin: A 10 Years’ Experience 输尿管支架和经皮肾造口术治疗胃肠道源性恶性输尿管梗阻的10年经验

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2020-12-08 DOI: 10.3390/gidisord2040041

E. De Lorenzis, E. Lievore, M. Turetti, A. Gallioli, B. Galassi, L. Boeri, E. Montanari

引用次数: 7

Utility of Direct Fast Scarlet Staining in the Histopathological Diagnosis of Eosinophilic Esophagitis: A Short Report 直接快速Scarlet染色在嗜酸性食管炎组织病理学诊断中的应用

Gastrointestinal disorders (Basel, Switzerland) Pub Date : 2020-11-09 DOI: 10.3390/gidisord2040040

Takuji Tanaka, N. Watanabe, Tomohiro Kato, R. Aoki, T. Ogiso, A. Sugiyama, E. Tomita

{"title":"Utility of Direct Fast Scarlet Staining in the Histopathological Diagnosis of Eosinophilic Esophagitis: A Short Report","authors":"Takuji Tanaka, N. Watanabe, Tomohiro Kato, R. Aoki, T. Ogiso, A. Sugiyama, E. Tomita","doi":"10.3390/gidisord2040040","DOIUrl":"https://doi.org/10.3390/gidisord2040040","url":null,"abstract":"Eosinophilic esophagitis (EoE), an atopic disease of the esophagus, has become increasingly recognized over the last 15 years. The epidemiology of EoE has now been reported from many countries around the world. While the clinical diagnosis of this disease depends on the patient’s clinical manifestations, the final diagnosis should be made based on the histopathological examination of esophageal mucosal biopsies. In the diagnosis of EoE, to facilitate the appropriate treatment of patients, it is extremely important to precisely recognize the presence of eosinophils in biopsy specimens of the esophageal mucosa. If eosinophils are present, EoE patients should be referred to an allergist for appropriate management with dietary modification, pharmacological agents (including corticosteroids), and/or mechanical dilation of the esophagus. We herein present and recommend the use of direct fast scarlet staining for the easy and precise recognition of eosinophils in biopsy specimens of the esophageal mucosa, a technique that has been routinely used in our laboratory.","PeriodicalId":73131,"journal":{"name":"Gastrointestinal disorders (Basel, Switzerland)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3390/gidisord2040040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41568560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1